Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$3.92−0.08 (-2.00%)

Close on Nov 13, 2026Market cap $50.37MP/E –Yield –

Clene EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Clene's EPS for the twelve months ending Sep 30, 2026 was -$2.58. For fiscal 2021 it was -$3.20.

Period	Period end	Value	Change
FY2021	Dec 31, 2021	-$3.20	–
FY2020	Dec 31, 2020	-$22.00	–
FY2019	Dec 31, 2019	-$18.60	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$0.05	–
Q2 FY2026	Jun 30, 2026	-$1.08	–
Q1 FY2026	Mar 31, 2026	-$0.69	–
Q4 FY2025	Dec 31, 2025	-$0.86	–
Q3 FY2025	Sep 30, 2025	-$0.85	–
Q2 FY2025	Jun 30, 2025	-$0.78	–
Q1 FY2025	Mar 31, 2025	-$0.09	–
Q4 FY2024	Dec 31, 2024	-$1.61	–
Q3 FY2024	Sep 30, 2024	-$1.22	–
Q2 FY2024	Jun 30, 2024	-$1.06	–
Q1 FY2024	Mar 31, 2024	-$1.73	–
Q4 FY2023	Dec 31, 2023	-$1.58	–
Q3 FY2023	Sep 30, 2023	-$0.38	–
Q2 FY2023	Jun 30, 2023	-$5.84	-169.5%
Q1 FY2023	Mar 31, 2023	-$3.10	–
Q2 FY2022	Jun 30, 2022	-$1.40	–
Q1 FY2022	Mar 31, 2022	-$4.20	-582.8%
Q3 FY2021	Sep 30, 2021	$8.40	–
Q2 FY2021	Jun 30, 2021	-$1.00	–
Q1 FY2021	Mar 31, 2021	-$13.20	–
Q4 FY2020	Dec 31, 2020	$0.87	–
Q3 FY2020	Sep 30, 2020	-$11.80	–
Q2 FY2020	Jun 30, 2020	-$6.80	–
Q1 FY2020	Mar 31, 2020	-$4.60	–